Haleon Recognized by Fast Company as a 2025 Brands That Matter Honoree
- Haleon earns distinction in the Family of Brands category for building enduring trust and consumer connection
- Award highlights Haleon’s leadership in purposeful innovation and consumer impact
WARREN, N.J.–(BUSINESS WIRE)–
Haleon, a global leader in consumer health, today announced it has been honored in Fast Company’s 2025 Brands That Matter list in the Family of Brands category, which highlights companies that created cultural moments for multiple brands across their portfolios. The annual list recognizes organizations that demonstrate cultural relevance, meaningful consumer connection, and a clear commitment to purpose.
“We are incredibly proud to be recognized by Fast Company for the strength and impact of our brand portfolio,” said Katie Williams, U.S. Chief Marketing Officer at Haleon. “Our brands are trusted by people around the world, and this honor reflects our commitment to delivering science-backed products, transparent communication, and meaningful initiatives that support everyday health. At Haleon, we believe that helping people make better, more informed decisions about their health is not only our responsibility – it’s our purpose.”
Why this matters
Haleon’s diverse portfolio includes some of the world’s most recognized consumer health brands that are found in medicine cabinets across the globe – each with strong, distinct brand identities that resonate deeply with consumers, including Sensodyne, Centrum, Advil, Voltaren, Emergen-C, and Theraflu. Across the portfolio of brands, Haleon embeds insights-driven innovation, consumer education, and partnerships that not only meets consumer needs but also enriches the cultural conversations surrounding wellness, resilience, and informed self-care.
Haleon’s recognition in the Family of Brands category underscores the company’s ability to unite a diverse global portfolio under a shared mission – to put better everyday health in more hands. Through science-backed product innovations, consistent communications, cross-brand collaboration, and an unwavering focus on consumer wellbeing, Haleon’s brands have established deep emotional resonance and trust with individuals and families worldwide.
About Haleon
Haleon (NYSE: HLN) is a leading global consumer health company with a purpose to deliver better everyday health with Humanity. Haleon’s product portfolio spans six major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, Wellness, and Sexual Wellness. Built on trusted science, innovation, and deep human understanding, Haleon’s U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Eroxon, Excedrin, Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more. For more information on Haleon and its brands, please visit www.haleon.com or contact [email protected].
For more information, please visit www.haleon.com
About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with fellow business publication Inc. For more information, please visit fastcompany.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251212266703/en/
Media Contacts
Kelly Gramuglia
[email protected]
908-632-3389
KEYWORDS: New Jersey United States North America
INDUSTRY KEYWORDS: General Health Women Consumer Health Men
MEDIA:
| Logo |
 |